Colin Lindley currently serves as the Senior Vice President and Head of Global API Development, Industrialisation and Business Services at Evotec, a position held since July 2022. With extensive experience in the pharmaceutical industry, Colin's career includes significant roles at Aptuit from 2007 to October 2022, where responsibilities ranged from Vice President of API Chemistry to Senior Project Manager. Prior positions include managerial and project leadership roles at Evotec and Oxford Asymmetry, as well as a technical officer role at Knoll Pharma. Colin holds a Master of Business Administration from The Open University, a Level 5 Diploma in Management from the Chartered Management Institute, a PRINCE2 Practitioner certification, and a Bachelor of Science with Honours in Applied Chemistry from Nottingham Trent University.